Science Explorer Back to mapMap

Most cited papers from Covance (United Kingdom)

What are the most cited papers from Covance (United Kingdom)?

The most cited paper from Covance (United Kingdom) is "Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development" (W REDFERN, Leif G. Carlsson, Alice E. Davis et al., 2003), with 1,548 citations. Next come "Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis" (981) and "A Highly Durable RNAi Therapeutic Inhibitor of PCSK9" (773).

Showing 50 of 60 papers. Every paper with more than 98 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development W REDFERN, Leif G. Carlsson, Alice E. Davis et al. · Cardiovascular Research Apr 2003 1,548
2 Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis Teresa Coelho et al. · New England Journal of Medicine Open access 28 Aug 2013 981
3 A Highly Durable RNAi Therapeutic Inhibitor of PCSK9 Kevin J. Fitzgerald, Suellen White, Anna Borodovsky et al. · New England Journal of Medicine Open access 13 Nov 2016 773
4 Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens David Kirkland, Marilyn J. Aardema, Leigh M. Henderson et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 24 Jun 2005 758
5 Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks Philippa D. Darbre, Philip W. Harvey · Journal of Applied Toxicology Open access 16 May 2008 704
6 Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial Kevin J. Fitzgerald, Maria D. Frank-Kamenetsky, Svetlana Shulga‐Morskaya et al. · The Lancet Open access 3 Oct 2013 580
7 The safety of chitosan as a pharmaceutical excipient Paul Baldrick · Regulatory Toxicology and Pharmacology 28 Sep 2009 560
8 Reliable Comet assay measurements for detecting DNA damage induced by ionising radiation and chemicals T. S. Kumaravel, Awadhesh N. Jha · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 19 Apr 2006 523
9 Fourth International Workgroup on Genotoxicity testing: Results of the in vivo Comet assay workgroup Brian Burlinson, Raymond R. Tice, Günter Speit et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 28 Nov 2006 511
10 How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop David Kirkland et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 14 Jan 2007 443
11 Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial Gregory G. Schwartz et al. · American Heart Journal Open access 6 Aug 2014 415
12 Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2 Wendy Painter, Wayne Holman, Jim A. Bush et al. · Antimicrobial Agents and Chemotherapy Open access 3 Mar 2021 401
13 Population norms for the EQ-5D-3L: a cross-country analysis of population surveys for 20 countries Mathieu F. Janssen, Ágota Szende, J. Cabases et al. · The European Journal of Health Economics Open access 14 Feb 2018 354
14 Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging—A Systematic Review and Meta-Analysis Irıs D. Nagtegaal, Nikki Knijn, Niek Hugen et al. · Journal of Clinical Oncology ReviewOpen access 23 Feb 2017 320
15 Proton transfer and hydrogen bonding in the organic solid state: a combined XRD/XPS/ssNMR study of 17 organic acid–base complexes Joanna S. Stevens, Stephen J. Byard, Colin C. Seaton et al. · Physical Chemistry Chemical Physics Open access 5 Nov 2013 287
16 Population Norms for the EQ-5D Bas Janssen, Ágota Szende Book chapterOpen access 26 Sep 2013 259
17 Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial Andreas Goette, José Luís Merino, Michael D. Ezekowitz et al. · The Lancet 6 Sep 2016 249
18 Semaglutide improves postprandial glucose and lipid metabolism, and delays first‐hour gastric emptying in subjects with obesity Julie Hjerpsted, Anne Flint, Ashley M. Brooks et al. · Diabetes Obesity and Metabolism Open access 23 Sep 2017 241
19 A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins David Kirkland, Lesley Reeve, David G. Gatehouse et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 15 Jan 2011 239
20 Reduction of misleading (“false”) positive results in mammalian cell genotoxicity assays. I. Choice of cell type Paul Fowler, Katie Smith, Jamie K. Young et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2 Dec 2011 226
21 Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate Tracy S. Zimmermann, Verena Karsten, Amy Chan et al. · Molecular Therapy Open access 2017 217
22 An evaluation framework for new approach methodologies (NAMs) for human health safety assessment Stanley T. Parish, Michael Aschner, Warren Casey et al. · Regulatory Toxicology and Pharmacology Open access Feb 2020 208
23 Self-Reported Population Health: An International Perspective Based on EQ-5D Ágota Szende, M.B. Janssen, J.M. Cabasés et al. · Value in Health Open access 22 Oct 2013 197
24 Animal models of mechanisms of SARS‐CoV‐2 infection and COVID‐19 pathology Simon J. Cleary, Simon C. Pitchford, Richard T. Amison et al. · British Journal of Pharmacology Open access 28 May 2020 192
25 Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS Claire E. Hall et al. · Cell Reports Open access May 2017 189
26 Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19 George R. Painter, Michael G. Natchus, Oren J. Cohen et al. · Current Opinion in Virology ReviewOpen access 18 Jun 2021 177
27 Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: A follow-up to an ECVAM workshop David Kirkland, Peter Kasper, Lutz Müller et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 12 Apr 2008 177
28 Bioanalytical Approaches to Analyzing Peptides and Proteins by LC–MS/MS Matthew Ewles, Lee Goodwin · Bioanalysis Jun 2011 167
29 Parabens can enable hallmarks and characteristics of cancer in human breast epithelial cells: a review of the literature with reference to new exposure data and regulatory status Philippa D. Darbre, Philip W. Harvey · Journal of Applied Toxicology 22 Jul 2014 167
30 Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: Genotoxic effects of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells Eric K. Dufour, T. S. Kumaravel, Gerhard J. Nohynek et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 22 Jun 2006 162
31 Assessment of the genotoxic and carcinogenic risks of p-nitrophenol when it is present as an impurity in a drug product Gary M. Eichenbaum, Mark Johnson, David Kirkland et al. · Regulatory Toxicology and Pharmacology 15 Jun 2009 157
32 Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women? Philip W. Harvey, Philippa D. Darbre · Journal of Applied Toxicology May 2004 156
33 Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safety Lynn Purkins, Nolan Wood, Katie Greenhalgh et al. · British Journal of Clinical Pharmacology Open access 17 Nov 2003 149
34 Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit Robert L. Clark, Tacey E. K. White, Sally A. Clode et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology Dec 2004 143
35 Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up meeting of the international workshop on Genotoxicity testing—Aberdeen, Scotland, 2003—Assay acceptance criteria, positive controls, and data evaluation Martha M. Moore et al. · Environmental and Molecular Mutagenesis 30 Jun 2005 143
36 Interpretation of the biological relevance of genotoxicity test results: the importance of thresholds David Kirkland, Lutz Müller · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2000 141
37 Safety assessment of astaxanthin-rich microalgae biomass: Acute and subchronic toxicity studies in rats John S. Stewart, Åke Lignell, Annette Frost Pettersson et al. · Food and Chemical Toxicology 11 Jun 2008 139
38 Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing V. Thybaud, Marilyn J. Aardema, Julie M. Clements et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 28 Nov 2006 135
39 Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test Elisabeth Lorge, Makoto Hayashi, Silvio Albertini et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 15 Jun 2008 134
40 Significance of the detection of esters of p‐hydroxybenzoic acid (parabens) in human breast tumours Philip W. Harvey, David J. Everett · Journal of Applied Toxicology 2004 132
41 Intravenous Safety and Pharmacokinetics of a Novel Dimerizer Drug, AP1903, in Healthy Volunteers John D. Iuliucci, Stuart D. Oliver, Steven K. Morley et al. · The Journal of Clinical Pharmacology Aug 2001 130
42 Nonproliferative and Proliferative Lesions ofthe Gastrointestinal Tract, Pancreas andSalivary Glands of the Rat and Mouse Thomas Nolte, Patricia Brander-Weber, Charles A. Dangler et al. · Journal of Toxicologic Pathology Open access 2016 129
43 A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks Ana Santos Cravo, Jim A. Bush, Girish C. Sharma et al. · Regulatory Toxicology and Pharmacology Open access 18 Oct 2016 128
44 NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods Maria Lorna A. De Leoz et al. · Molecular & Cellular Proteomics Open access162 authors 7 Oct 2019 126
45 Predictive Models for Carcinogenicity and Mutagenicity: Frameworks, State-of-the-Art, and Perspectives Emilio Benfenati, Romualdo Benigni, David M. DeMarini et al. · Journal of Environmental Science and Health Part C May 2009 124
46 The inequity of informal payments for health care: The case of Hungary Ágota Szende, Anthony J. Culyer · Health Policy 26 May 2005 123
47 A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer Gerlinde Pilkington, Angela Boland, Tamara J. Brown et al. · Thorax ReviewOpen access 6 Feb 2015 118
48 Evaluation of the rodent micronucleus assay by a 28‐day treatment protocol: Summary of the 13th Collaborative Study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Environmental Mutagen Society of Japan (JEMS)–Mammalian Mutagenicity Study Group (MMS) Shuichi Hamada et al. · Environmental and Molecular Mutagenesis 2001 118
49 In vivo erythrocyte micronucleus assay Makoto Hayashi, James T. MacGregor, David G. Gatehouse et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis 7 Dec 2006 114
50 An assessment of the genotoxicity and human health risk of topical use of kojic acid [5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one] Gerhard J. Nohynek, David Kirkland, Daniel R. Marzin et al. · Food and Chemical Toxicology 11 Oct 2003 113

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.